Riccardo Muglia

ORCID: 0000-0003-0092-5065
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Liver Disease and Transplantation
  • Liver Disease Diagnosis and Treatment
  • Radiomics and Machine Learning in Medical Imaging
  • Organ Transplantation Techniques and Outcomes
  • Renal cell carcinoma treatment
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Advanced X-ray and CT Imaging
  • Pancreatic and Hepatic Oncology Research
  • COVID-19 diagnosis using AI
  • Nutrition and Health in Aging
  • MRI in cancer diagnosis
  • Advanced Radiotherapy Techniques
  • Gallbladder and Bile Duct Disorders
  • Abdominal vascular conditions and treatments
  • Pediatric Hepatobiliary Diseases and Treatments
  • Renal and Vascular Pathologies
  • Transplantation: Methods and Outcomes
  • Radiation Dose and Imaging
  • COVID-19 and healthcare impacts
  • Pancreatitis Pathology and Treatment
  • COVID-19 Clinical Research Studies
  • Multiple and Secondary Primary Cancers
  • Renal and related cancers
  • Cardiac tumors and thrombi

Ospedale Papa Giovanni XXIII
2021-2025

University of Milano-Bicocca
2023-2025

Humanitas University
2018-2023

IRCCS Humanitas Research Hospital
2018-2021

Istituti di Ricovero e Cura a Carattere Scientifico
2020-2021

Lombardy (Italy) was the epicentre of COVID-19 pandemic in March 2020. The healthcare system suffered from a shortage ICU beds and oxygenation support devices. In our Institution, most patients received chest CT at admission, only interpreted visually. Given proven value quantitative analysis (QCT) setting ARDS, we tested QCT as an outcome predictor for COVID-19.

10.1007/s00330-020-07013-2 article EN other-oa European Radiology 2020-06-26

ABSTRACT Background and Aims Management of ultrasound (US)‐guided percutaneous liver biopsy (PLB) lacks standardisation. Despite the low risk major complications (< 1%), repeated blood counts up to 4 h in‐hospital observation are typically recommended. We aimed assess complication rates predictors in a large cohort patients undergoing US‐PLB across three Italian tertiary centres. included all from January 2018 December 2023. collected clinical, biochemical procedural features (needle...

10.1111/liv.70078 article EN cc-by-nc-nd Liver International 2025-04-01

To retrospectively evaluate the accuracy of a novel software platform for assessing completeness percutaneous thermal ablations.Ninety hepatocellular carcinomas (HCCs) in 50 patients receiving ultrasound-guided microwave ablation (MWA) that resulted apparent technical success at 24-h post-ablation computed tomography (CT) and with ≥1-year imaging follow-up were randomly selected from 320 HCC database (2010-2016). Using volumetric registration software, pre-ablation CT volumes HCCs without...

10.1080/02656736.2019.1569267 article EN cc-by International Journal of Hyperthermia 2019-01-01

Background: Over the last two decades, augmented reality (AR) has been used as a visualization tool in many medical fields order to increase precision, limit radiation dose, and decrease variability among operators. Here, we report first vivo study of novel AR system for guidance percutaneous interventional oncology procedures. Methods: Eight patients with 15 liver tumors (0.7−3.0 cm, mean 1.56 + 0.55) underwent thermal ablations using (i.e., Endosight system). Prior intervention, were...

10.3390/cancers14051312 article EN Cancers 2022-03-03

Sarcopenia has been associated with lower overall survival in patients cirrhosis and hepatocellular carcinoma (HCC) undergoing surgical resection, TACE, TARE, or transplantation. This monocentric study evaluated the prognostic significance of sarcopenia affected by HCC who received bland transarterial embolization (TAE) therapy, analyzing its impact on treatment-related complications. All consecutive underwent 1st TAE between March 2011 July 2019 our Institution were retrospectively studied....

10.1371/journal.pone.0232371 article EN cc-by PLoS ONE 2020-06-17

Background: The LI-RADS classification is widely used for the hepatocellular carcinoma (HCC) risk stratification of liver nodules in cirrhotic patients. evaluation nodule enhancement, which a major criterion, commonly relies on qualitative assessment. This study aims to investigate potential role material density (MD) parameters iodine maps spectral computed tomography (SCT) discriminate between (v2018 CORE) categories Methods: Dual-energy SCT scans patients with suspected HCC, taken March...

10.3390/diagnostics15060725 article EN cc-by Diagnostics 2025-03-14

Abstract Portal hypertension resulting from non-cirrhotic extrahepatic portal vein obstruction is a cause of severe morbidity related to variceal bleeding in children. In patients not eligible for Meso-Rex bypass, rescue interventions refractory have traditionally included surgical porto-systemic shunts or transjugular intrahepatic shunt (TIPS), which alter the normal physiology liver perfusion and expose children long-term complications. recanalization recently described technique aims...

10.1007/s00247-025-06218-1 article EN cc-by Pediatric Radiology 2025-03-19

Abstract OBJECTIVE: Lombardy (Italy) was the epicentre of COVID-19 pandemic in March 2020. The healthcare system suffered from a shortage ICU beds and oxygenation support devices. In our Institution, most patients received chest CT at admission, only interpreted visually. Given proven value Quantitative analysis (QCT) setting ARDS, we tested QCT as an outcome predictor for COVID-19.METHODS: We performed single centre retrospective study on hospitalized January 25th, 2020 to April 28th 2020,...

10.21203/rs.3.rs-30481/v1 preprint EN cc-by Research Square (Research Square) 2020-05-22

Locoregional therapies for hepatocellular carcinoma (HCC) include endovascular treatments such as chemoembolization (TACE) and bland embolization (TAE). TACE is the most adopted technique, despite a lack of definitive evidence superiority over TAE, which less costly better tolerated due to absence chemotherapy. However, few studies have reported data on TAE monotherapy unresectable HCC. We report our results in cohort 230 patients with HCC treated (TAE 40-100micron microparticles,...

10.1371/journal.pone.0227711 article EN cc-by PLoS ONE 2020-01-14

10.1007/s00270-020-02575-6 article EN CardioVascular and Interventional Radiology 2020-07-06

Abstract Background Chronic total occlusion (CTO) of the portal vein is one main causes hypertension, which may result in life-threatening complications often managed by interventional radiology (IR). The aim this study to report innovative experience with percutaneous revascularization therapy management CTO paediatric and adult patients. Materials methods From January 2020 December 2023 consecutive patients severe hypertension resulting from who underwent attempts at recanalization were...

10.1186/s42155-024-00496-w article EN cc-by CVIR Endovascular 2024-11-23

Embolisation of the parenchymal tract is a key step after any other transhepatic or transplenic percutaneous portal vein catheterization since eventual venous bleeding difficult to control and may require surgical management. Different techniques have been proposed perform embolisation. The aim this study compare safety efficacy different haemostasis tract.All interventional procedures with access (excluding ipsilateral embolisation) from January 2010 July 2020, in two tertiary hospitals,...

10.1186/s42155-022-00321-2 article EN cc-by CVIR Endovascular 2022-09-05

Purpose: To evaluate technical and clinical outcomes of intraoperative (laparoscopic/laparotomic) microwave ablation on HCC. Materials Methods: This is a retrospective single-center study evaluating consecutive patients treated for very early/early-stage HCC with from 1 July 2017 to 30 June 2023. In these patients, percutaneous US-guided approach was excluded due the nodule’s suboptimal visibility or harmful location liver resection deep position adherences. Data about stage, surgical...

10.3390/cancers16010092 article EN Cancers 2023-12-24
Coming Soon ...